Allergy Therapeutics Plc (AGY) – Strategy, SWOT and Corporate Finance Report
- Pages: 51
- Published: November 2023
- Report Code: MLPH57668FSA
Allergy Therapeutics Plc (AGY) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers aluminum-free allergy vaccines and diagnostics. Allergy Therapeutics product portfolio includes Grass Modified Allergen Tyrosine Adsorbed (MATA), Tree MATA, Ragweed MATA, Bee Venom Subcutaneous Immunotherapy (SCIT), and Wasp venom SCIT among others. It also offers allergen extracts used for skin prick testing. The company’s diagnostics products comprise Pollen, Moulds, Arthropods, Epithelia and others. It has an operational presence in Germany, Italy, Spain, Austria, Switzerland, the Netherlands and the UK, among others. Allergy Therapeutics is headquartered in Worthing, West Sussex, the UK.
Scope
• Detailed information on Allergy Therapeutics Plc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Allergy Therapeutics Plc in the form of a SWOT analysis
• An in-depth view of the business model of Allergy Therapeutics Plc including a breakdown and examination of key business segments
• News about Allergy Therapeutics Plc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Allergy Therapeutics Plc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Allergy Therapeutics Plc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Allergy Therapeutics Plcs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
HAL Allergy BV
Stallergenes Greer Ltd
Roxall Medizin GmbH
Laboratorios LETI SLU
Biomay AG
Allergopharma GmbH & Co KG
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.